RxDoctor Payments Data

Diane Teal

Nurse Practitioner · Gadsden, ALNPI 1871911818

Payments from drug & device makers

$1,158in general payments, 2019–2025

Across 53 payments — averaging $21.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$421
  • Johnson & Johnson$134
  • Novartis$85
  • Novo Nordisk$69
  • Shield Therapeutics Inc$62
  • Pfizer$57
  • plus $329 from 13 others

What the payments were for

  • Food & beverage$78067%
  • Education$37833%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,158 in reported general payments places this provider in the 70th percentile of 1,505 nurse practitioner providers in Alabama.

See all nurse practitioner providers in Alabama

Medicare billing

Part B allowed, 2024
$15,737
Medicare patients
58
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron13$7,591
Estradiol147$4,591
Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet21$1,947
ValacyclovirValacyclovir Hcl23$773
ProgesteroneProgesterone, Micronized21$738
Clobetasol Propionate13$496
Fluconazole66$449
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip12$316
Metronidazole26$290
Norgestimate-Ethinyl Estradiol11$217
Nystatin14$181
Mupirocin14$127

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$421$7,59113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,505 nurse practitioner providers in Alabama.

Other nurse practitioner in Gadsden

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →